This article is part of a series of case studies on the use of NGS and digital tools to drive precision oncology in the Asia Pacific region. Scroll to the bottom of the article for the full list. In 2017, the Korean government began to provide selective health insurance coverage so that next-generation sequencing (NGS) […]
NGS and precision oncology in South Korea: insights from Prof Kim Jee-Hyun Read More »
This article is part of a series of case studies on the use of NGS and digital tools to drive precision oncology in the Asia Pacific region. Scroll to the bottom of the article for the full list. Cancer is a high-priority disease in Hong Kong, but although treatment success can be improved with next-generation
NGS and precision oncology in Hong Kong: insights from Dr Lam Tai-Chung Read More »
As the global burden of cancer increases every year, oncology professionals are seeking targeted, precise and sensitive methods to identify tumours and monitor their growth. For over a decade, many have used serum tumour markers (STM) as part of their diagnostic toolkit. To better understand how STMs are currently used and what the future holds
In this recent webinar hosted by Roche Diagnostics Asia Pacific, Assoc. Professor Svetlana Cherepanoff, a staff specialist anatomical pathologist at St Vincent’s Hospital in Australia with research interests in ocular pathology, shares her experience using digital pathology, NGS and digital collaboration tools for better and more accurate diagnosis. Cherepanoff gives examples of how these technologies
Digital pathology and MDTs in ophthalmology: a case study from Australia Read More »
Professor Keith Kerr, Chair of Pulmonary Pathology of the University of Aberdeen, raises the need for a holistic approach when it comes to informing a patient’s journey. In this recent webinar hosted by Roche Diagnostics Asia Pacific, Professor Kerr highlights that communication and mutual understanding within members of a team underpins successful patient management, from
Oncologist-pathologist communication underpins successful care teams Read More »
Professor Tony Mok, Chairman of the Department of Clinical Oncology at the Chinese University of Hong Kong, is widely regarded as one of Asia’s top experts in lung cancer management. In this recent webinar hosted by Roche Diagnostics Asia Pacific, he describes how multidisciplinary teams can optimise treatment plans for patients with non-small cell lung
Optimising NSCLC treatment: insights from Professor Tony Mok Read More »
To enable value-based healthcare, several important steps are needed: design of a care pathway for a given disease, definition of a patient-centered outcome indicator set, systematic collection of relevant outcomes (including Patient Reported Outcome Measures or PROMS), and careful selection of case-mix variables. The aim of this project was to investigate if this is feasible
Value-based care in lung cancer: a case study from Belgium Read More »
Over the last two decades, clinicians and laboratories gained greater understanding about genomic alterations in non-small cell lung cancer (NSCLC). With this wealth of knowledge comes the need for adapting protocols to optimise testing for disease diagnosis and treatment. In this recent webinar collaboration between AstraZeneca and Roche Diagnostics Asia Pacific, Dr Chih-Hsi Kuo, director
The evolution of liquid biopsy in EGFR testing for lung cancer Read More »
Listen to perspectives from Professor Tan Puay Hoon, Senior Consultant Histopathologist and Chairman of the Division of Pathology at Singapore General Hospital, as she discusses triple negative breast cancer from a pathologist’s standpoint. In this recent webinar supported by the Singapore Society of Oncology, Prof Tan highlights the WHO guidelines for evaluating tumour infiltrating lymphocytes
A pathologist’s perspective on triple negative breast cancer Read More »
Mortality rates for patients with non-small-cell lung carcinoma (NSCLC) dropped sharply in 2020 following the approval of a number of drugs targeting the EGFR mutation, which is common in Asian patient populations. In this recent webinar, Dr Noemi Reguart, a medical oncologist at the Hospital Clinic in Barcelona, stresses the importance of using biomarker testing
EGFR testing in lung cancer: 2020 updates from Dr Noemi Reguart Read More »
Subscribe to Lab Insights latest news and update
Join over 3,000 HCPs receiving insights in their inbox.
